For: | Alvares-da-Silva MR, Oliveira CPMS, Stefano JT, Barbeiro HV, Barbeiro D, Soriano FG, Farias AQ, Carrilho FJ, D’Albuquerque LAC. Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation. World J Gastroenterol 2014; 20(26): 8667-8673 [PMID: 25024624 DOI: 10.3748/wjg.v20.i26.8667] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8667.htm |
Number | Citing Articles |
1 |
Bruna Cherubini Alves, Juliana Paula Bruch-Bertani, Clara Belle Manfroi Galinatti, Claudia Czarnobay Garbin, Mário Reis Álvares-da-Silva, Valesca Dall’Alba. Obesity, dynapenia and high cardiovascular risk co-exist in post-liver transplant setting: results of a cross-sectional study. Clinics and Research in Hepatology and Gastroenterology 2019; 43(2): 140 doi: 10.1016/j.clinre.2018.09.005
|
2 |
S. He, N. A. Le, J. K. Frediani, P. D. Winterberg, R. Jin, R. Liverman, A. Hernandez, R. L. Cleeton, M. B. Vos. Cardiometabolic risks vary by weight status in pediatric kidney and liver transplant recipients: A cross‐sectional, single‐center study in the USA. Pediatric Transplantation 2017; 21(6) doi: 10.1111/petr.12984
|
3 |
Victoria Potoupni, Maria Georgiadou, Eftychia Chatzigriva, Georgia Polychronidou, Erietta Markou, Christos Zapantis Gakis, Ioanna Filimidou, Myriam Karagianni, Dimitrios Anastasilakis, Kleo Evripidou, Argyro Ftergioti, Marianthi Togkaridou, Nikolaos Tsaftaridis, Apostolos Apostolopoulos, Stergios A Polyzos. Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis. Journal of Gastroenterology and Hepatology 2021; 36(11): 3002 doi: 10.1111/jgh.15631
|
4 |
Lucilene Rezende Anastácio, Marina Chaves de Oliveira, Kiara Gonçalves Diniz, Adaliene Matos Versiane Ferreira, Agnaldo Soares Lima, Maria Isabel Toulson Davisson Correia, Eduardo Garcia Vilela. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant. Nutrition 2016; 32(9): 921 doi: 10.1016/j.nut.2015.12.038
|
5 |
Meike Dirks, Henning Pflugrad, Anita B. Tryc, Anna-Kristina Schrader, Xiaoqi Ding, Heinrich Lanfermann, Elmar Jäckel, Harald Schrem, Jan Beneke, Hannelore Barg-Hock, Jürgen Klempnauer, Christine S. Falk, Karin Weissenborn. Impact of immunosuppressive therapy on brain derived cytokines after liver transplantation. Transplant Immunology 2020; 58: 101248 doi: 10.1016/j.trim.2019.101248
|
6 |
Steven Van Laecke, Thomas Malfait, Eva Schepers, Wim Van Biesen. Cardiovascular disease after transplantation: an emerging role of the immune system. Transplant International 2018; 31(7): 689 doi: 10.1111/tri.13160
|
7 |
Giuseppina Pisano, Anna L Fracanzani, Lucio Caccamo, Maria F Donato, Silvia Fargion. Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World Journal of Gastroenterology 2016; 22(40): 8869-8882 doi: 10.3748/wjg.v22.i40.8869
|
8 |
James M. Neuberger, Wolf O. Bechstein, Dirk R.J. Kuypers, Patrizia Burra, Franco Citterio, Sabina De Geest, Christophe Duvoux, Alan G. Jardine, Nassim Kamar, Bernhard K. Krämer, Herold J. Metselaar, Frederik Nevens, Jacques Pirenne, Manuel L. Rodríguez-Perálvarez, Didier Samuel, Stefan Schneeberger, Daniel Serón, Pavel Trunečka, Giuseppe Tisone, Teun van Gelder. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients. Transplantation 2017; 101(4S): S1 doi: 10.1097/TP.0000000000001651
|
9 |
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
|